Medics Autonomously Stopping Hemorrhage (MASH) DARPA-PS-25-34

Solicitation DARPA-PS-25-34 Copied Notice ID 6d826add665048888c9317b598e61991 Copied DEPT OF DEFENSE — DEF ADVANCED RESEARCH PROJECTS AGCY

SAM.gov

Posted

Sep 16, 2025

Deadline

Nov 25, 2025

Set-aside

None

NAICS

541714

PSC

AC12

Summary

AI-generated · Sep 17, 2025

DARPA seeks proposals to develop demonstrator autonomous systems capable of stabilizing torso hemorrhage in forward medical sites without surgeon intervention, with at least 48 hours to reach definitive care. Proposals should integrate multi-modal automated bleed detection and localization with automated, minimally invasive robotic end effectors and sensors.

The program aims to push pre-hospital hemorrhage control to a 48-hour window, stop lethal torso bleeding without a surgeon, and provide a path for minimally invasive surgery to enter the trauma market by leveraging full autonomy.

The Defense Advanced Research Projects Agency (DARPA) is soliciting proposals to develop demonstrator autonomous systems to stabilize torso hemorrhage without need of a surgeon in forward medical sites, providing 48+ hours to reach definitive care. The Medics Autonomously Stopping Hemorrhage (MASH) program is seeking approaches that merge multi-modal automated bleed detection and localization with automated, minimally invasive robotic end effectors and sensors. MASH s vision is to push the standard of pre-hospital hemorrhage control to 48 hours; stop lethal forms of torso hemorrhage without a surgeon; and provide minimally invasive surgery (MIS) a path to enter the trauma market and utilize full autonomy.

From Solicitation posted on Sep 16, 2025